Még nem toboroz
Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
NCT07908147· Korai 1. fázis· Olivia Newton-John Cancer Research Institute· Forrás
Még nem toboroz
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT07634289· 2. fázis· Olivia Newton-John Cancer Research Institute· Forrás
Még nem toboroz
Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
NCT07712770· Korai 1. fázis· Olivia Newton-John Cancer Research Institute· Forrás
Toboroz
Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy
NCT07640191· iVEAcare· Forrás
Toboroz
Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
NCT07287202· 1/2. fázis· Sovargen· Forrás
Toboroz
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT07518186· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
NCT07567846· 1/2. fázis· Genentech, Inc.· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849· 3. fázis· Incyte Corporation· Forrás
Toboroz
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT07222761· 3. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
NCT06932562· 3. fázis· European Myeloma Network B.V.· Forrás
Toboroz
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
NCT07059845· 2. fázis· AbbVie· Forrás
Toboroz
PRIORITY-CONNECT 2 Trial
NCT06976710· Surgical Outcomes Research Centre (SOuRCe)· Forrás
Toboroz
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
NCT07149857· 2. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma
NCT07138222· Peter MacCallum Cancer Centre, Australia· Forrás
Toboroz
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06896916· 1. fázis· AbbVie· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
NCT07202078· 2/3. fázis· Monash University· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
NCT07202091· 2/3. fázis· Monash University· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
NCT07202052· 2/3. fázis· Monash University· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
NCT07202065· 2/3. fázis· Monash University· Forrás
Meghívásos bevonás
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
NCT06908226· 3. fázis· Longboard Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
NCT06456463· 2. fázis· Stemline Therapeutics, Inc.· Forrás
Toboroz
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
NCT06613009· 1. fázis· Innovent Biologics (Suzhou) Co. Ltd.· Forrás
Fut, nem toboroz
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
NCT06588686· 2. fázis· Vicore Pharma AB· Forrás
Fut, nem toboroz
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
NCT06719141· 3. fázis· Longboard Pharmaceuticals· Forrás
Toboroz
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048· 3. fázis· Corvus Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás
Fut, nem toboroz
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394· 3. fázis· Longboard Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
NCT06550895· 2. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142· 3. fázis· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Forrás
Még nem toboroz
Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke
NCT06495671· University of Melbourne· Forrás
Toboroz
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
NCT06112314· 3. fázis· Immunocore Ltd· Forrás
Toboroz
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
NCT05892510· 2/3. fázis· University of Melbourne· Forrás
Toboroz
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961· 2/3. fázis· CSL Behring· Forrás
Fut, nem toboroz
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
NCT05899985· Ferronova Pty Ltd· Forrás
Fut, nem toboroz
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
NCT06157541· 1/2. fázis· Queensland Institute of Medical Research· Forrás
Toboroz
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
NCT05658497· Biogen· Forrás
Fut, nem toboroz
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
NCT05257083· 3. fázis· Stichting European Myeloma Network· Forrás
Toboroz
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT05730036· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390· Helsinki University Central Hospital· Forrás
Toboroz
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
NCT05800665· 1. fázis· Genentech, Inc.· Forrás
Toboroz
Alleviant ALLAY-HF Study
NCT05685303· Alleviant Medical, Inc.· Forrás
Fut, nem toboroz
Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial
NCT05556720· 3. fázis· Monash University· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
NCT05678621· 2/3. fázis· Monash University· Forrás
Toboroz
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
NCT05180097· 2. fázis· Canadian Cancer Trials Group· Forrás
Toboroz
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
NCT05169177· University of Sydney· Forrás
Toboroz
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
NCT05533697· 1/2. fázis· ModernaTX, Inc.· Forrás
Toboroz
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171· 2/3. fázis· Panbela Therapeutics, Inc.· Forrás
Fut, nem toboroz
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382286· 3. fázis· Gilead Sciences· Forrás
Fut, nem toboroz
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382299· 3. fázis· Gilead Sciences· Forrás
Fut, nem toboroz
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
NCT05338970· 3. fázis· Daiichi Sankyo· Forrás
Showing 50 of 70.